American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Abdel-Wahab
    Abdel-Wahab
  10. Palomba
    Palomba

Groups

  1. Department of Medicine (3977)
  2. Hematologic Malignancies, Division of (3778)
  3. Center for Hematologic Malignancies (3661)
  4. GSK Faculty (1588)
  5. Adult Leukemia (1338)
  6. Sloan Kettering Institute Faculty (1074)
  7. Bone Marrow Transplant (975)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (954)
  9. Lymphoma (939)
  10. Tow Center for Developmental Oncology (TCDO) (881)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3977)
  2. Hematologic Malignancies, Division of (3778)
  3. Center for Hematologic Malignancies (3661)
  4. GSK Faculty (1588)
  5. Adult Leukemia (1338)
  6. Sloan Kettering Institute Faculty (1074)

More Groups

People
  1. Sergio Giralt (346)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (308)
  5. Martin Tallman (300)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5165)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5537)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of ponatinib therapy duration among real-world chronic phase chronic myeloid leukemia (CP-CML) patients in the US
    Meeting Abstract

    Mauro, M. J.; McGarry, L. J.; Lustgarten, S.; Huang, H.
    Blood (2016)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Differential outcome of patients with primary refractory vs. relapsed peripheral T-cell lymphoma: Analysis from a prospective multicenter US cohort study
    Meeting Abstract

    Lansigan, F.; Horwitz, S. M.; Pinter-Brown, L. C.; Carson, K. R.; Shustov, A. R.; Rosen, S. T.; Pro, B.; Hsi, E. D.; Federico, M.; Gisselbrecht, C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Incidence, severity, day 100 treatment efficacy and therapy toxicity of cytomegalovirus (CMV) infections with early pre-emptive therapy in adult cord blood (CB) transplant recipients
    Meeting Abstract

    Lau, C.; Bhatt, V.; Dahi, P. B.; Devlin, S.; Yoo, Y.; Adel, N. G.; Mazis, C.; Perales, M.; Giralt, S. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation and active cancer
    Meeting Abstract

    Laube, E. S.; Yu, A.; Gupta, D.; Miao, Y.; Samedy, P.; Wills, J.; Harnicar, S. J.; Soff, G. A.; Mantha, S.
    Blood (2016)

    Fulltext@MSK | Save
  • The development of a qPCR assay for the evaluation of the dendritic cell chimeric antigen receptor transcriptome
    Meeting Abstract

    Leyfman, Y.; Daniyan, A.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • The VITAL amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 3 study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction
    Meeting Abstract

    Liedtke, M.; Merlini, G.; Landau, H.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Risk of progression in monoclonal gammopathy of undetermined significance (MGUS): Results from a population-based screening study
    Meeting Abstract

    Lindqvist, E. K.; Lund, S. H.; Costello, R.; Burton, D.; Korde, N. S.; Mailankody, S.; Björkholm, M.; Eiriksdottir, G.; Launer, L. J.; Harris, T. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Evaluation of immune recovery following autologous hematopoietic cell transplantation in HIV-related lymphoma: Results of the BMT CTN 0803/AMC 071 Trial
    Meeting Abstract

    Makowski, M.; Ahmed, E.; Schlotter, S.; Pearson, R.; Kitzler, R.; Alvarnas, J. C.; Le Rademacher, J.; Wang, Y.; Little, R. F.; Akpek, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Outcome of initial observation in mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Ying, Z.; Alperovich, A.; Dogan, A.; Hamlin, P. A. Jr; Moskowitz, C. H.; Portlock, C. S.; Zelenetz, A. D.; Zhang, Z.; Woo, K. M.; more...
    Blood (2016)

    Fulltext@MSK | Save